About Galvanize

Galvanize is a biomedical platform company operating at the convergence of engineering, biology, and healthcare delivery, aiming to deliver life-changing solutions to patients and their doctors.

We create Pulsed Electric Field technologies capable of targeting cells involved in disease processes, in ways unparalleled to other devices or drugs.

We study our technologies in well designed clinical trials to ensure safety and efficacy.

We partner with doctors and healthcare systems so that patients can access our therapies.

Learn more about the Galvanize science and technology platform

Galvanize Leadership

Jonathan Waldstreicher, MD

Founder

BIO
Kevin Taylor
Chief Operating Officer
BIO
Bill Krimsky, MD
Chief Medical Officer
BIO
Name TK
Chief Financial Officer
BIO

Doug Godshall

Chairman and CEO, Galvanize

Jonathan Waldstreicher, MD

Founder

Steve Anheier

Chief Financial Officer

Kevin Taylor

Chief Operating Officer

Deb Sheffield

Chief Regulatory Officer

Bill Green

Senior Vice President, Sales and Marketing

William S. Krimsky, MD, FCCP, DAABIP

Chief Medical Officer

Gabe McHugh

Chief Commercial Officer, Galvanize

Board of Directors

Doug Godshall

Chairman and CEO, Galvanize

Seth Harrison, MD

Founder and Managing Partner, ATP

Antoine Papiernik

Chairman & Managing Partner, Sofinnova Partners

Zack Scott, MD

General Partner, Norwest Venture Partners

David Lewis

Managing Partner, Gilmartin Capital

Laura Francis

CEO and Board Member of SI-BONE, Inc.

Investors

Galvanize was created and incubated by ATP (Apple Tree Partners).

Other investors in Galvanize include Intuitive Surgical, Gilmartin Capital, and T. Rowe Price; Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors and Longaeva.